Karly A. Stanley

ORCID: 0000-0002-2172-1910

Also affiliated with Huntsman Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression”.

Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0474

N/A

0DataRank · unranked

8 citations

Tursun Turapov, David A. Kircher, William J. Burnett, Christopher M. Stehn, Kayla O’Toole +13 more

Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin

Cells(2023)10.3390/cells12020325

N/A

0DataRank · unranked

1 citations

Ian A. MacDonald, Karly A. Stanley, Nathaniel A. Hathaway, Sarah C. Wistner

Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin

UNC Libraries(2023)10.17615/6rvf-dk44

N/A

0DataRank · unranked

0 citations

Nathaniel A. Hathaway, Karly A. Stanley, Sarah C. Wistner, Ian A. MacDonald

Targeting FAK to Potentiate Immune Checkpoint Therapy in Solid Tumors

Journal of Cancer Immunology(2025)10.33696/cancerimmunol.7.109

N/A

0DataRank · unranked

7 citations

Sheri L. Holmen, Karly A. Stanley

Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.101943

N/A

0DataRank · unranked

12 citations

Tursun Turapov, David A. Kircher, Karly A. Stanley, Katie M. Culver, A. Paulina Medellin +7 more